Hillstream Biopharma Inc

Company Profile

Hillstream Biopharma Inc had its IPO on 2022-01-12 under the ticker symbol HILS.

The company operates in the Healthcare sector and Biotechnology industry. Hillstream Biopharma Inc has a staff strength of 1 employees.

Stock update

Shares of Hillstream Biopharma Inc opened at $0.23 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.21 - $0.23, and closed at $0.21.

This is a -1.71% slip from the previous day's closing price.

A total volume of 170,093 shares were traded at the close of the day’s session.

In the last one week, shares of Hillstream Biopharma Inc have slipped by -11.49%.

Hillstream Biopharma Inc's Key Ratios

Hillstream Biopharma Inc has a market cap of $4.23 million, indicating a price to book ratio of 0.8831 and a price to sales ratio of 0.

In the last 12-months Hillstream Biopharma Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Hillstream Biopharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Hillstream Biopharma Inc’s operating margin was 0% while its return on assets stood at -77.97% with a return of equity of -147.31%.

In Q2, Hillstream Biopharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Hillstream Biopharma Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.76 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Hillstream Biopharma Inc’s profitability.

Hillstream Biopharma Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -3.5126. Its price to sales ratio in the trailing 12-months stood at 0.

Hillstream Biopharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$4.60 million

Total Liabilities

$1.53 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Hillstream Biopharma Inc ended 2024 with $4.60 million in total assets and $0 in total liabilities. Its intangible assets were valued at $4.60 million while shareholder equity stood at $3.07 million.

Hillstream Biopharma Inc ended 2024 with $0 in deferred long-term liabilities, $1.53 million in other current liabilities, 1690.00 in common stock, $-20409634.00 in retained earnings and $0 in goodwill. Its cash balance stood at $3.90 million and cash and short-term investments were $3.90 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Hillstream Biopharma Inc’s total current assets stands at $4.60 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.14 million and inventory worth $0.

In 2024, Hillstream Biopharma Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Hillstream Biopharma Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.21

52-Week High

$2.059

52-Week Low

$0.19

Analyst Target Price

$

Hillstream Biopharma Inc stock is currently trading at $0.21 per share. It touched a 52-week high of $2.059 and a 52-week low of $2.059. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.31 and 200-day moving average was $0.59 The short ratio stood at 0.2 indicating a short percent outstanding of 0%.

Around 3890.9% of the company’s stock are held by insiders while 89% are held by institutions.